The Department of Health and Human Services will create a Foundry for American Biotechnology to produce technological solutions to address health security threats and enhance daily medical care, the agency announced today. The foundry will be located in Manchester, N.H., and managed in conjunction with the Advanced Regenerative Manufacturing Institute led by DEKA Research Corp., as part of a public-private partnership with HHS’ Office of the Assistant Secretary for Preparedness and Response. Its first project, a partnership with the Defense Advanced Research Projects Agency, will focus on maturing and validating small, automated devices that could go to disaster locations to make necessary medicines on site.

Related News Articles

Headline
More than 300 citizens returned to the U.S. Sunday from a quarantined cruise ship off the coast of Japan, including 14 who tested positive for novel…
Headline
Five public health labs already conducting influenza surveillance in the U.S. will test specimens for novel coronavirus (COVID-19) if they test negative for…
Headline
As hospitals and health systems raise concerns over possible shortages of personal protective equipment, including respirators, the Centers for Disease Control…
Headline
The Centers for Disease Control and Prevention today said new reagents will be manufactured and sent to state laboratories that reported inconclusive results…
Headline
CDC recommends the use of a hierarchy of controls in health care settings to prevent infectious disease transmission. These include: engineering controls to…
Headline
The Centers for Disease Control and Prevention recently updated its guidance and resources for U.S. health care personnel working in environments possibly…